Analysis of the Shifting Rare Eye Diseases Market Landscape
DelveInsight Business Research, a prominent player in the rare disease market, has recently released a comprehensive analysis of the shifting landscape in the market... Read more.
Hovione Acquires ExtremoChem to Boost Delivery of Biopharmaceuticals
Hovione, a leading Contract Development and Manufacturing Organization (CDMO) specializing in pharmaceutical development and manufacturing, has successfully acquired... Read more.
Federal Court Enters Consent Decree Against Arizona-based Company for Distribution of Unapproved Contraceptive Drugs
Today, the U.S. District Court for the District of Arizona entered a consent decree of permanent injunction ordering Smart Women’s Choice, Inc., an Arizona-based... Read more.
Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks
This technical data was produced for the U. S. Government under Contract Number 75FCMC18D0047, and is subject to Federal Acquisition Regulation Clause 52.227-14,... Read more.
FDA Issues Class I Recall on Fresenius Medical Care’s Sanxin Single Use Sterile Syringes
The Food and Drug Administration (FDA) has recently classified the recall of Fresenius Medical Care’s Sanxin Single Use Sterile Syringes as a Class I recall... Read more.
Various Eye Drops by Kilitch Healthcare India Limited: Recall – Due to Potential Safety Reasons
AUDIENCE: Consumer, Health Professional, Ophthalmology ISSUE: Kilitch Healthcare India Limited is recalling the eye drops products with all lots within expiry with... Read more.
Eli Lilly’s Bold Move: €2 Billion Investment and 1,000 Jobs in New German Plant Signals Strategic Expansion
In a strategic move that underscores its commitment to expanding its global operations, U.S. pharmaceutical giant Eli Lilly (LLY.N) is set to make a substantial... Read more.
The Top 10 Scarlet Fever Remedies You Should Know
Scarlet fever, a bacterial infection caused by Group A Streptococcus bacteria, primarily affects children. The first notable description of what might have been... Read more.
Astellas to Acquire Propella Therapeutics in Strategic Merger
In a major development in the pharmaceutical landscape, Astellas Pharma Inc. (TSE: 4503), led by President and CEO Naoki Okamura, and Propella Therapeutics, Inc.,... Read more.
University of Tsukuba and Astellas Announce Strategic Partnership to Propel Drug Discovery and Research
In a groundbreaking move, the University of Tsukuba and Astellas Pharma Inc. have formalized a strategic partnership aimed at catalyzing the digitalization of drug... Read more.